Natera, Inc. (NTRA) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NTRA Revenue Growth
Revenue Breakdown (FY 2025)
NTRA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
NTRA Revenue Analysis (2013–2024)
As of May 6, 2026, Natera, Inc. (NTRA) generated trailing twelve-month (TTM) revenue of $2.12 billion, reflecting explosive growth of +34.7% year-over-year. The most recent quarter (Q3 2025) recorded $592.2 million in revenue, up 8.3% sequentially.
Looking at the longer-term picture, NTRA's 5-year compound annual growth rate (CAGR) stands at +41.2%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $1.70 billion in 2024, representing a new all-time high.
Revenue diversification analysis shows NTRA's business is primarily driven by Product (100%), and Licensing and other (0%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including EXAS (+17.7% YoY), ILMN (+1.2% YoY), and CGEN (-27.6% YoY), NTRA has outperformed the peer group in terms of revenue growth. Compare NTRA vs EXAS →
NTRA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NTRACurrent | $2.1B | +34.7% | +41.2% | -13.1% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 ILMN | $4.3B | +1.2% | +6.0% | 19.9% | |
 CGEN | $28M | -27.6% | - | -53.4% | |
 MYRG | $3.7B | +13.1% | +10.2% | 4.4% | |
 PACB | $154M | -10.7% | +11.1% | -308.0% |
NTRA Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1.70B | +56.7% | $1.02B | 60.3% | $-222,294,000 | -13.1% |
| 2023 | $1.08B | +32.0% | $492.7M | 45.5% | $-446,245,000 | -41.2% |
| 2022 | $820.2M | +31.1% | $364.0M | 44.4% | $-541,040,000 | -66.0% |
| 2021 | $625.5M | +60.0% | $307.1M | 49.1% | $-468,174,000 | -74.8% |
| 2020 | $391.0M | +29.3% | $187.4M | 47.9% | $-216,277,000 | -55.3% |
| 2019 | $302.3M | +17.3% | $126.9M | 42.0% | $-116,287,000 | -38.5% |
| 2018 | $257.7M | +22.1% | $91.6M | 35.6% | $-114,628,000 | -44.5% |
| 2017 | $210.9M | -2.8% | $71.3M | 33.8% | $-134,027,000 | -63.5% |
| 2016 | $217.1M | +14.0% | $81.5M | 37.5% | $-96,488,000 | -44.4% |
| 2015 | $190.4M | +19.5% | $77.5M | 40.7% | $-59,838,000 | -31.4% |
Full NTRA Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See NTRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NTRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NTRA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNTRA — Frequently Asked Questions
Quick answers to the most common questions about buying NTRA stock.
Is NTRA's revenue growth accelerating or slowing?
NTRA revenue is accelerating at +34.7% year-over-year, exceeding the 5-year CAGR of +41.2%. TTM revenue reached $2.1B. Growth momentum has increased versus prior periods.
What is NTRA's long-term revenue growth rate?
Natera, Inc.'s 5-year revenue CAGR of +41.2% reflects the sustained expansion pattern. Current YoY growth of +34.7% is above this long-term average.
How is NTRA's revenue distributed by segment?
NTRA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.